Aardvark investors face class action lawsuit

A shareholder rights firm said investors in Aardvark Therapeutics are being notified of a pending securities class action tied to the company’s IPO documents and later securities purchases. The notice cites a lead plaintiff motion deadline of Oct. 13, 2026.